Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
about
Targeting ROR1 identifies new treatment strategies in hematological cancers.Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer.Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility.Therapeutic T cell engineering.An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors.Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells.Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy.Interaction between ROR1 and MuSK activation complex in myogenic cells.Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells.Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France.miR‑30a inhibits epithelial‑mesenchymal transition and metastasis in triple‑negative breast cancer by targeting ROR1.Analysis of ROR1 Protein Expression in Mice with Reconstituted Human Immune System Components.A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL.Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1.
P2860
Q36346494-39B4AA39-6B4E-457B-9EF4-5B1938753712Q37723027-597E39AC-96F2-4A86-8600-F6F19DF567ECQ38429183-D052AD26-C977-4D67-B516-5B237ED9DB01Q40199809-34E582A2-9AA7-41BA-A4C4-16A38023489EQ41252003-B64EA5FB-6F36-44DB-BC9E-C24C2489A76CQ44829588-6A5C69F7-0084-4B10-8D1A-60BB9607782EQ47137229-5A4674EA-645C-4E23-B5F8-FA380BEC6B2FQ47193084-6F8FD1E9-A6E9-4446-9174-B9317C0FCC87Q47239662-3ED27578-8C4D-40A0-9244-A490DB97BCCCQ48124146-D8034004-04E1-4193-BBCA-9D9E99540D90Q48517212-D34F1684-99B7-4E95-B433-CC98F0E24304Q52564396-8AC7400B-AA93-4755-947F-97D3B53058BFQ54955028-551C08D5-11A9-443B-9CC9-F9A33655D686Q54977394-23ABC25D-9796-46FE-9284-6B7F95FAB58AQ54977612-D7986C06-1DD7-4BEF-A4B0-E3F8E71ED8EBQ55039454-85267126-395C-4635-B42E-BB7610C87A18
P2860
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@en
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@nl
type
label
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@en
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@nl
prefLabel
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@en
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues.
@nl
P2093
P2860
P1476
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
@en
P2093
Ashwini Balakrishnan
Benjamin G Hoffstrom
Carolina Berger
Daniel Sommermeyer
Florencia G Jalikis
Julie Randolph-Habecker
Lisa K Koch
Paula L Kosasih
Peggy L Porter
Stanley R Riddell
P2860
P304
P356
10.1158/1078-0432.CCR-16-2083
P407
P50
P577
2016-11-16T00:00:00Z